Gail Naughton

Gail K.
Naughton is the founder of Advanced Tissue Sciences, Inc., founded in 1991, where the title held was Vice Chairman in 2002.
Dr. Naughton is the founder of Histogen, Inc., founded in 2007, holding the title Chairman & Chief Executive Officer from 2009 to 2020.
Dr. Naughton is the founder of Histogen, Inc., founded in 2005, holding the title Chief Scientific & Business Development Officer from 2017 to 2021.
Current jobs include Chairman at La Jolla Institute For Immunology, Executive Chairman at BiOHIP, Inc. since 2021, Independent Director at TherapeuticsMD, Inc. since 2020, Director at Octet Medical, Inc., and Professor at City University of New York.
Former jobs include Independent Director at C.
R.
Bard, Inc. (New Jersey) from 2011 to 2017, Director at Kratos Technology & Training Solutions, Inc., Director at Celera Corp.
from 2008 to 2011, Director at DermTech Operations, Inc., Independent Director at Plus Therapeutics, Inc. from 2014 to 2018, Director at City of Hope National Cancer Institute, Director at Centre For Commercialization of Regenerative Medicine, Independent Director at CEL-SCI Corp.
from 2022 to 2024, Advisor at Proteus RM LLC (Venture Capital), Dean at Sdsu Fowler College of Business from 2002 to 2011, and Head-Regenerative Therapeutics & Commercialization at HippoFi, Inc. Education includes an MBA from the University of California, Los Angeles, undergraduate degree from St. Francis College, and graduate and doctorate degrees from New York University School of Medicine.